Contoli, Marco;
Porsbjerg, Celeste;
Fritzsching, Benedikt;
Buchs, Sarah;
Rask Larsen, Julie;
Freemantle, Nick;
(2023)
Long-term, real-world effects of allergy immunotherapy in children with allergic rhinitis and pre-existing asthma - a subgroup analysis of the REACT study.
Allergologie
, 46
(10)
Preview |
Text
Freemantle_Contoli et al. 25-Jan-23.pdf Download (694kB) | Preview |
Abstract
Background: Randomised controlled trials (RCTs) have demonstrated the efficacy of allergy immunotherapy (AIT) in allergic rhinitis (AR) and the disease-modifying effects of the SQ grass sublingual immunotherapy (SLIT)-tablet.// Objective: To assess real-world, long-term effectiveness and safety across AIT subgroups: route of administration, therapeutic allergen, persistence to AIT, and SQ grass SLIT-tablet.// Methods: The primary outcome of AR prescriptions from a retrospective cohort study (REACT; 2007–2017) was assessed across pre-specified AIT subgroups in AR subjects with, and without AIT prescriptions (controls). Safety was assessed as anaphylaxis ≤2 days of the first AIT prescription. Subgroup follow-up continued until samples were <200 subjects.// Results: Subcutaneous immunotherapy (SCIT) and SLIT-tablets showed similarly greater reductions in AR prescriptions than controls (SCIT versus SLIT-tablets: Year 3, p=0.15; Year 5, p=0.43). Comparably greater reductions in AR prescriptions were observed for grass- and house dust mite (HDM)-specific AIT than controls, but significantly smaller reductions were observed for tree-specific AIT (tree versus HDM, and versus grass: Years 3 and 5, p<0.0001). Persistence to AIT was associated with greater reductions in AR prescriptions versus non-persistence (persistence versus nonpersistence: Year 3, p=0.09; Year 5, p=0.006). SQ grass SLIT-tablet showed sustained reductions versus controls for up to 7 years (Year 3, p=0.002; Year 5, p=0.03). Rates of anaphylactic shock were low (0.000–0.092%), with no events for SQ SLIT-tablets.// Conclusion: These results demonstrate real-world, long-term effectiveness of AIT, complement disease-modifying effects observed in SQ grass SLIT-tablet RCTs, and highlight the importance of using newer evidence-based AIT products for tree pollen AR.
| Type: | Article |
|---|---|
| Title: | Long-term, real-world effects of allergy immunotherapy in children with allergic rhinitis and pre-existing asthma - a subgroup analysis of the REACT study |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.dustri.com/nc/journals-in-german/mag/a... |
| Language: | German |
| Additional information: | This version is the author-accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Allergy, Life Sciences & Biomedicine, Science & Technology |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10189210 |
Archive Staff Only
 |
View Item |
